These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

139 related items for PubMed ID: 10676837

  • 1. Fever, rash, and pancytopenia following vancomycin rechallenge in the presence of ceftazidime.
    Shahar A, Berner Y, Levi S.
    Ann Pharmacother; 2000 Feb; 34(2):263-4. PubMed ID: 10676837
    [No Abstract] [Full Text] [Related]

  • 2. Drug rash, eosinophilia, and systemic symptoms syndrome: Two pediatric cases demonstrating the range of severity in presentation--A case of vancomycin-induced drug hypersensitivity mimicking toxic shock syndrome and a milder case induced by minocycline.
    Vinson AE, Dufort EM, Willis MD, Eberson CP, Harwell JI.
    Pediatr Crit Care Med; 2010 Jul; 11(4):e38-43. PubMed ID: 20407399
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Ceftazidime in combination with glycopeptide antibiotic is an effective first-line therapy for patients undergoing high-dose therapy with autologous peripheral blood stem cell support.
    Egerer G, Goldschmidt H, Streich N, Ehrhard I, Sonntag HG, Haas R.
    Support Care Cancer; 1999 Sep; 7(5):336-42. PubMed ID: 10483819
    [Abstract] [Full Text] [Related]

  • 5. Probable hypersensitivity reaction to vancomycin associating rash, fever and neutropenia.
    Dauby N, Fink W, Seyler L, Luce S, Nouwynck C, Tas S, Jacobs F.
    Acta Clin Belg; 2012 Sep; 67(3):226-8. PubMed ID: 22897075
    [Abstract] [Full Text] [Related]

  • 6. Vancomycin-induced reversible pancytopenia and rash in a 16-month-old boy with osteomyelitis: A case report
.
    Leng B, Yan G, Li T, Hou N.
    Int J Clin Pharmacol Ther; 2020 Apr; 58(4):242-246. PubMed ID: 32000885
    [Abstract] [Full Text] [Related]

  • 7. Fatal toxic epidermal necrolysis associated with ceftazidine and vancomycin therapy: a report of two cases.
    Thestrup-Pedersen K, Hainau B, Al'Eisa A, Al'Fadley A, Hamadah I.
    Acta Derm Venereol; 2000 Apr; 80(4):316-7. PubMed ID: 11028879
    [No Abstract] [Full Text] [Related]

  • 8. A sixty-five-year-old man with rash, fever, and generalized weakness.
    Bajaj P, Prematta MJ, Ghaffari G.
    Allergy Asthma Proc; 2011 Apr; 32(1):e1-3. PubMed ID: 21262091
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Delayed hypersensitivity reaction to vancomycin.
    Marik PE, Ferris N.
    Pharmacotherapy; 1997 Apr; 17(6):1341-4. PubMed ID: 9399623
    [Abstract] [Full Text] [Related]

  • 11. A randomized, double-blind trial comparing ceftobiprole medocaril with vancomycin plus ceftazidime for the treatment of patients with complicated skin and skin-structure infections.
    Noel GJ, Bush K, Bagchi P, Ianus J, Strauss RS.
    Clin Infect Dis; 2008 Mar 01; 46(5):647-55. PubMed ID: 18225981
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. The importance of vancomycin in drug rash with eosinophilia and systemic symptoms (DRESS) syndrome.
    Blumenthal KG, Patil SU, Long AA.
    Allergy Asthma Proc; 2012 Mar 01; 33(2):165-71. PubMed ID: 22525393
    [Abstract] [Full Text] [Related]

  • 15. [Vancomycin-induced DRESS syndrome: a case report].
    Cariou ME, Kaabar M, Cailliez P, Lorléac'h A, Prades-Grandgirard N, Jacobzone-Lévêque C, Schmitt F.
    Ann Biol Clin (Paris); 2013 Mar 01; 71(2):190-5. PubMed ID: 23587585
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Tolerability of teicoplanin in 117 hospitalized adults with previous vancomycin-induced fever, rash, or neutropenia: a retrospective chart review.
    Hung YP, Lee NY, Chang CM, Lee HC, Wu CJ, Chen PL, Lee CC, Chung CH, Ko WC.
    Clin Ther; 2009 Sep 01; 31(9):1977-86. PubMed ID: 19843487
    [Abstract] [Full Text] [Related]

  • 19. Histamine release during rapid vancomycin administration.
    Renz C, Lynch J, Thurn J, Moss J.
    Inflamm Res; 1998 Sep 01; 47 Suppl 1():S69-70. PubMed ID: 9561421
    [No Abstract] [Full Text] [Related]

  • 20. Aztreonam and ceftazidime: evidence of in vivo cross allergenicity.
    Pérez Pimiento A, Gómez Martínez M, Mínguez Mena A, Trampal González A, de Paz Arranz S, Rodríguez Mosquera M.
    Allergy; 1998 Jun 01; 53(6):624-5. PubMed ID: 9689350
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.